Alvotech and Dr. Reddy’s partner to prepare a candidate for biosimilator (pembrolizumab)

Alvotech (Nasdaq:Target) and Dr. Reddy Laboratories (NYSE:RDY) A CAITRRRAVADA (PEMBrolizumab) for global markets has entered the cooperation and licensing agreement for a biocimilar candidate preparation, production, production and trade.

The Cain (Pembrolizumab) is shown for the treatment of a large number of cancers. World sales in 2024